Literature DB >> 19647320

HLA-DM mediates peptide exchange by interacting transiently and repeatedly with HLA-DR1.

Kedar Narayan1, Katherine W Su, Chih-Ling Chou, Stanislav Khoruzhenko, Scheherazade Sadegh-Nasseri.   

Abstract

The peptide editor HLA-DM (DM) catalyzes the exchange of peptides bound to MHC class II molecules within antigen presenting cells by generating a "peptide-receptive" MHC class II conformation (MHC(receptive)) to which peptides readily bind and rapidly unbind. While recent work has uncovered the determinants of DM recognition and effector functions, the nature of MHC(receptive) and its interaction with DM remains unclear. Here, we show that DM induces but does not stabilize MHC(receptive) in the absence of peptides. We demonstrate that DM is out-competed by certain superantigens, and increasing solvent viscosity inhibits DM-induced peptide association. We suggest that DM mediates peptide exchange by interacting transiently and repeatedly with MHC class II molecules, continually generating MHC(receptive). The simultaneous presence of peptide and DM in the milieu is thus crucial for the efficient generation of specific peptide-MHC class II complexes over time.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647320      PMCID: PMC2743474          DOI: 10.1016/j.molimm.2009.07.001

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  32 in total

1.  The glucocorticoid receptor: rapid exchange with regulatory sites in living cells.

Authors:  J G McNally; W G Müller; D Walker; R Wolford; G L Hager
Journal:  Science       Date:  2000-02-18       Impact factor: 47.728

2.  Determination of the HLA-DM interaction site on HLA-DR molecules.

Authors:  R C Doebele; R Busch; H M Scott; A Pashine; E D Mellins
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

3.  Transmembrane domain-mediated colocalization of HLA-DM and HLA-DR is required for optimal HLA-DM catalytic activity.

Authors:  D A Weber; C T Dao; J Jun; J L Wigal; P E Jensen
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

4.  The kinetic basis of peptide exchange catalysis by HLA-DM.

Authors:  J A Zarutskie; R Busch; Z Zavala-Ruiz; M Rushe; E D Mellins; L J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

Review 5.  Bacterial superantigens.

Authors:  T Proft; J D Fraser
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

6.  Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides.

Authors:  Achal Pashine; Robert Busch; Michael P Belmares; Jason N Munning; Robert C Doebele; Megan Buckingham; Gary P Nolan; Elizabeth D Mellins
Journal:  Immunity       Date:  2003-08       Impact factor: 31.745

Review 7.  The convergent roles of tapasin and HLA-DM in antigen presentation.

Authors:  Scheherazade Sadegh-Nasseri; Mingnan Chen; Kedar Narayan; Marlene Bouvier
Journal:  Trends Immunol       Date:  2008-02-07       Impact factor: 16.687

8.  Energetic asymmetry among hydrogen bonds in MHC class II*peptide complexes.

Authors:  B J McFarland; J F Katz; C Beeson; A J Sant
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

9.  Role for intracellular proteases in the processing and transport of class II HLA antigens.

Authors:  J S Blum; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  HLA-DM recognizes the flexible conformation of major histocompatibility complex class II.

Authors:  C L Chou; S Sadegh-Nasseri
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

View more
  19 in total

1.  Structural Insights Into HLA-DM Mediated MHC II Peptide Exchange.

Authors:  Corrie A Painter; Lawrence J Stern
Journal:  Curr Top Biochem Res       Date:  2011

2.  Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide.

Authors:  Liusong Yin; Peter Trenh; Abigail Guce; Marek Wieczorek; Sascha Lange; Jana Sticht; Wei Jiang; Marissa Bylsma; Elizabeth D Mellins; Christian Freund; Lawrence J Stern
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

3.  Rapid microsphere-assisted peptide screening (MAPS) of promiscuous MHCII-binding peptides in Zika virus envelope protein.

Authors:  Mason R Smith; Luke F Bugada; Fei Wen
Journal:  AIChE J       Date:  2019-06-11       Impact factor: 3.993

4.  A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  J Immunol Methods       Date:  2014-02-25       Impact factor: 2.303

Review 5.  Selection of immunodominant epitopes during antigen processing is hierarchical.

Authors:  Scheherazade Sadegh-Nasseri; AeRyon Kim
Journal:  Mol Immunol       Date:  2018-08-24       Impact factor: 4.407

Review 6.  Exogenous antigens bind MHC class II first, and are processed by cathepsins later.

Authors:  Scheherazade Sadegh-Nasseri; AeRyon Kim
Journal:  Mol Immunol       Date:  2015-08-05       Impact factor: 4.407

7.  HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives.

Authors:  Liusong Yin; J Mauricio Calvo-Calle; Omar Dominguez-Amorocho; Lawrence J Stern
Journal:  J Immunol       Date:  2012-09-10       Impact factor: 5.422

Review 8.  Measurement of Peptide Binding to MHC Class II Molecules by Fluorescence Polarization.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  Curr Protoc Immunol       Date:  2014-08-01

Review 9.  Conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection.

Authors:  Scheherazade Sadegh-Nasseri; Sateesh Natarajan; Chih-Ling Chou; Isamu Z Hartman; Kedar Narayan; AeRyon Kim
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

Review 10.  What to do with HLA-DO/H-2O two decades later?

Authors:  Robin Welsh; Nianbin Song; Scheherazade Sadegh-Nasseri
Journal:  Immunogenetics       Date:  2019-01-26       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.